ParaGard TV Spot Misrepresents Contraceptive’s Risks, US FDA Says
Executive Summary
The agency took issue with distracting visuals and reliance on superimposed text in a television spot for CooperSurgical's copper-containing intrauterine device, which is regulated as a drug. This is the third untitled letter from the US FDA to target promotions for women’s health products in the past eighteen months.